We found that the expression of PD-1 (PDCD1/CD279) was lower in ESCA samples and that the differences in the corresponding ligand (tumor cell) CD274 (PD-L1) were non-significant across patients and groups (Supplementary Figure S5D). Here, PDCD1 is linked to neoplasm.